Search
for
Sort by
Research 541–570 of 1000+
- From the Cochrane Library: Interventions for Nail Psoriasis
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Stem Cell‐Based Therapies for Skin Rejuvenation: A Systematic Review of Clinical Efficacy, Safety, and Underlying Mechanisms
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Mesotherapy: From Historical Notes to Scientific Evidence and Future Prospects
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review
- Polynucleotides HPT ‐Based Dermal Filler for Skin Rejuvenation: A Prospective Clinical Investigation
- Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety
- Immune Cell-Targeting Biologics for Alopecia Areata: A New Paradigm in Precision Medicine
- A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair
- Randomized Clinical Trial to Evaluate the Effect of Probiotic Intake on Androgenic Alopecia
- Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
- The Pressurized Skin: A Review on the Pathological Effect of Mechanical Pressure on the Skin from the Cellular Perspective
- The JAK/STAT signaling pathway: from bench to clinic
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Toward Optimal Health: The Experts Discuss Facial Skin and Related Concerns in Women
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Alopecia in Association with Malignancy: A Review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- A Gender Hypothesis of sex disparities in adverse drug events
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Cancer-Related Alopecia Risk and Treatment
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database